Based on the Titan Pharmaceuticals Inc stock forecast from 0 analysts, the average analyst target price for Titan Pharmaceuticals Inc is not available over the next 12 months. Titan Pharmaceuticals Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Titan Pharmaceuticals Inc is Bearish, which is based on 1 positive signals and 5 negative signals. At the last closing, Titan Pharmaceuticals Inc’s stock price was USD 3.72. Titan Pharmaceuticals Inc’s stock price has changed by +1.36% over the past week, +2.48% over the past month and -48.74% over the last year.
No recent analyst target price found for Titan Pharmaceuticals Inc
No recent average analyst rating found for Titan Pharmaceuticals Inc
Company Overview Titan Pharmaceuticals Inc
Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases in the United States and internationally. It develops products based on ProNeura, a proprietary long-term drug delivery platform. It also develops TP-2021 in combination with ProNeura technology for the treatment of chronic pruritus, a severe and debilitating condition defined as itching of the skin lasting longer than six weeks; and Nalmefene implant program for the prevention of opioid relapse following detoxification of patients suffering opioid use disorder. The company was founded in 1991 and is based in South San Francisco, California. Read Less
Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases in the United States and internationally. It develops products based on ProNeura, a proprietary long-term drug delivery platform. It also develops TP-2021 in combina...Read More
Frequently Asked Questions About Titan Pharmaceuticals Inc (TTNP) Stock
Stock Target Advisor's fundamental analysis for Titan Pharmaceuticals Inc's stock is Bearish.
Unfortunately we do not have enough data on TTNP's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on TTNP's stock to indicate what its average analyst target is.
TTNP stock's Price/Earning ratio is 13.80.
Our analysis grades TTNP stock's Price / Earning ratio at F. This means that TTNP stock's Price/Earning ratio is above 64% of the stocks in the Biotechnology sector in the NSD exchange.
Based on this TTNP may be a overvalued for its sector.
The last closing price of TTNP's stock was USD 3.72.
The most recent market capitalization for TTNP is USD 3.34M.
Unfortunately we do not have enough analyst data on TTNP's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Titan Pharmaceuticals Inc's stock.
As per our most recent records Titan Pharmaceuticals Inc has 4 Employees.
Titan Pharmaceuticals Inc's registered address is 400 Oyster Point Boulevard, South San Francisco, CA, United States, 94080.
You can get more information about it from Titan Pharmaceuticals Inc's website at https://www.titanpharm.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
What not to like
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Frequently Asked Questions About Titan Pharmaceuticals Inc (TTNP) Stock
Stock Target Advisor's fundamental analysis for Titan Pharmaceuticals Inc's stock is Bearish.
Unfortunately we do not have enough data on TTNP's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on TTNP's stock to indicate what its average analyst target is.
TTNP stock's Price/Earning ratio is 13.80.
Our analysis grades TTNP stock's Price / Earning ratio at F. This means that TTNP stock's Price/Earning ratio is above 64% of the stocks in the Biotechnology sector in the NSD exchange.
Based on this TTNP may be a overvalued for its sector.
The last closing price of TTNP's stock was USD 3.72.
The most recent market capitalization for TTNP is USD 3.34M.
Unfortunately we do not have enough analyst data on TTNP's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Titan Pharmaceuticals Inc's stock.
As per our most recent records Titan Pharmaceuticals Inc has 4 Employees.
Titan Pharmaceuticals Inc's registered address is 400 Oyster Point Boulevard, South San Francisco, CA, United States, 94080.
You can get more information about it from Titan Pharmaceuticals Inc's website at https://www.titanpharm.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for TTNP !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
